Biofarm Bucure (BIO) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Biofarm Bucure (BIO) has a cash flow conversion efficiency ratio of 0.054x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (RON28.64 Million ≈ $6.58 Million USD) by net assets (RON534.78 Million ≈ $122.79 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Biofarm Bucure stock valuation for the company's overall valuation and market capitalisation.
Biofarm Bucure - Cash Flow Conversion Efficiency Trend (2019–2024)
This chart illustrates how Biofarm Bucure's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Biofarm Bucure Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Biofarm Bucure ranked by their cash flow conversion efficiency. Explore earnings quality score of Biofarm Bucure to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Corem Property Group AB (publ)
ST:CORE-PREF
|
0.019x |
|
Corem Property Group AB (publ)
ST:CORE-B
|
0.001x |
|
MM Forgings Limited
NSE:MMFL
|
0.196x |
|
Anhui Fuhuang Steel Structure Co Ltd
SHE:002743
|
-0.012x |
|
Beijing Hanjian Heshan Pipeline Co Ltd
SHG:603616
|
-0.114x |
|
Horizon Technology Finance
NASDAQ:HRZN
|
0.029x |
|
Prince Pipes And Fittings Limited
NSE:PRINCEPIPE
|
0.121x |
|
Nanjing Julong Science & Technology Co Ltd Class A
SHE:300644
|
0.026x |
Annual Cash Flow Conversion Efficiency for Biofarm Bucure (2019–2024)
The table below shows the annual cash flow conversion efficiency of Biofarm Bucure from 2019 to 2024. View Biofarm Bucure (BIO) share price today for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-09-30 | RON478.26 Million ≈ $109.82 Million |
RON57.59 Million ≈ $13.22 Million |
0.120x | -34.47% |
| 2023-09-30 | RON434.41 Million ≈ $99.75 Million |
RON79.83 Million ≈ $18.33 Million |
0.184x | +140.68% |
| 2022-09-30 | RON380.06 Million ≈ $87.27 Million |
RON29.02 Million ≈ $6.66 Million |
0.076x | -63.27% |
| 2021-09-30 | RON332.79 Million ≈ $76.41 Million |
RON69.18 Million ≈ $15.89 Million |
0.208x | +53.41% |
| 2020-09-30 | RON291.55 Million ≈ $66.94 Million |
RON39.51 Million ≈ $9.07 Million |
0.136x | -52.22% |
| 2019-09-30 | RON257.23 Million ≈ $59.06 Million |
RON72.96 Million ≈ $16.75 Million |
0.284x | -- |
About Biofarm Bucure
Biofarm S.A. manufactures and sells medicines in Romania. The company offers a portfolio of products covering therapeutic areas, such as antiallergics, cardiovascular and circulatory, analgesics and antipyretics, dermatology, digestive and metabolic, endocrine, genitourinary, multivitamins, ophthalmology, musculoskeletal, respiratory and ENT, and neurology. It provides prescription and non-prescr… Read more